Natera

Lead Billing Strategy & Systems Analyst

United States

Natera Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
HealthcareIndustries

Requirements

Candidates should possess a Bachelor's degree, and at least 5 years of experience in healthcare billing, payer eligibility, and reimbursement. Strong analytical skills, including advanced SQL knowledge and experience with data visualization tools like Power BI and Excel, are required. Familiarity with systems such as AdvancedMD, Salesforce, and EMRs is also necessary.

Responsibilities

The Lead Billing Strategy & Systems Analyst will be responsible for data analytics and reporting, including writing SQL queries, conducting complex data analyses, creating dashboards, and delivering executive-level presentations. They will also perform workflow audits, identify gaps, and recommend improvements, serve as an internal SME on RCM processes, lead billing system configuration efforts, vet and implement new vendors, conduct QA reviews, and assist with EDI processes.

Skills

SQL
Snowflake
Power BI
Excel
Data Analytics
Healthcare Billing
Payer Eligibility
Reimbursement
Claims Auditing
System Configuration
AdvancedMD
Salesforce
EMRs

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Key Metrics

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI